A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP3700 in Healthy Male Subjects
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics (PK)
of single ascending oral doses of ASP3700 in healthy male subjects. This study will also
explore the effect of itraconazole (another drug) on the PK of ASP3700, as well as to
evaluate the safety and tolerability of ASP3700 alone and in combination with itraconazole in
healthy male subjects.